Jan H. von der Thüsen
Rank 61 by 10-year citations to CLAD papers (7 papers, 454 citations). "Visiting professor" (Dept. of Pathology, University of Antwerp); field: pathology.
As of . Primary source: ORCID record (role and affiliation entries are self-asserted).
Summary
Jan H. von der Thüsen. Role: ORCID lists "Visiting professor" (Dept. of Pathology, University of Antwerp); "Pathologist and associate professor" (Dept. of pathology, Erasmus MC). Basis of the role: ORCID employment entries without an end date (self-asserted by the record holder, may be out of date). Field indicated by the unit name: pathology (source: the same ORCID entries). Affiliation: University of Antwerp, Antwerp (BE); Erasmus MC, Rotterdam (NL). Basis: ORCID record, employment entries without an end date (self-asserted, may be out of date). The whole-count rank depends substantially on consensus or guideline papers. Counts in the OpenAlex corpus (retrieved 2026-10-10): 7 papers and 454 citations over ten years; 2 first-author and 0 last-author papers. Ranks: main 61, excluding consensus papers 252, first or last author 134. The method is stated once on the People list page. Linked papers are the most-cited corpus papers of this author.
Citation ranks (10 years)
| Main rank | Rank excluding consensus papers | Rank by first or last author papers |
|---|---|---|
| 61 of 800 | 252 of 794 | 134 of 512 |
Citations: 454 in total, 153 excluding consensus and guideline papers (1 of this author's papers excluded), 56 on first or last author papers (2 first, 0 last).
Ranking method: see the methodology note at the top of the People list and the full methodology document.
Role and field
- Role
- "Visiting professor" (Dept. of Pathology, University of Antwerp); "Pathologist and associate professor" (Dept. of pathology, Erasmus MC)
- Role status
- verified from ORCID (self-asserted entries; may be out of date)
- Role basis
- ORCID employment entries without an end date (self-asserted by the record holder, may be out of date)
- Field
- pathology
- Field basis
- the same ORCID entries
Only what a cited source supports is stated. Entries marked self-asserted come from the person's own ORCID record. The field is taken from the name of the unit, not inferred from the person's name.
Details
- affiliation
- University of Antwerp, Antwerp (BE); Erasmus MC, Rotterdam (NL)
- papers 10y
- 7
- fractional papers 10y
- 0.81
- citations 10y
- 454
- fractional citations 10y
- 36.9
- ranking retrieved
- 2026-10-10
- orcid
- 0000-0001-9699-4860
- openalex author id
- A5003308528
- merged open alex profiles
- 1
- affiliation basis
- ORCID record, employment entries without an end date (self-asserted, may be out of date)
- papers excluding consensus 10y
- 6
- citations excluding consensus 10y
- 153
- consensus papers excluded 10y
- 1
- first author papers 10y
- 2
- last author papers 10y
- 0
- lead author citations 10y
- 56
- lead author papers 10y
- 2
Sources and links
- ORCID record (role and affiliation entries are self-asserted) (primary)
- OpenAlex author profile (ranking source)
- Most-cited CLAD paper in corpus: Chronic lung allograft dysfunction: Definition and update of restrictive allograft syndrome―A consensus report from the Pulmonary Council of the ISHLT (The Journal of Heart and Lung Transplantation, 2019); 301 citations; DOI 10.1016/j.healun.2019.03.008
- Most-cited CLAD paper in corpus: The histomorphological spectrum of restrictive chronic lung allograft dysfunction and implications for prognosis (Modern Pathology, 2018); 56 citations; DOI 10.1038/modpathol.2017.180
- Most-cited CLAD paper in corpus: When tissue is the issue: A histological review of chronic lung allograft dysfunction (American Journal of Transplantation, 2020); 48 citations; DOI 10.1111/ajt.15864
- Most-cited CLAD paper in corpus: Identification and characterization of chronic lung allograft dysfunction patients with mixed phenotype: A single‐center study (Clinical Transplantation, 2020); 26 citations; DOI 10.1111/ctr.13781
- Most-cited CLAD paper in corpus: The pleural mesothelium and transforming growth factor-β1 pathways in restrictive allograft syndrome: A pre-clinical investigation (The Journal of Heart and Lung Transplantation, 2019); 21 citations; DOI 10.1016/j.healun.2019.02.001
- ORCID employment entries (source of the role)
Related
Links from this record
Known gaps in this record
- centre membership relation (not asserted)
- funding and conflicts of interest
- only the top-30 entries were checked by hand for ID merges and splits
- whole-count rank depends substantially on consensus or guideline papers; see the rank excluding consensus papers
- whole-count rank depends substantially on consensus or guideline papers; see the rank excluding consensus papers
Information resource only. Not medical advice. Not a substitute for the care of the patient's transplant team.